Cardio Diagnostics Holdings, Inc. Profile Avatar - Palmy Investing

Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc.

Biotechnology
US, Chicago [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of CDIO's Analysis
CIK: - CUSIP: 14159C103 ISIN: US14159C1036 LEI: - UEI: -
Secondary Listings
CDIO has no secondary listings inside our databases.